[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100588728":3},{"organization":4,"armGroups":7,"interventions":20,"overallOfficials":25,"centralContacts":29,"locations":35,"responsibleParty":52,"collaborators":25,"id":54,"slug":55,"hasResults":56,"nctId":57,"briefTitle":58,"officialTitle":58,"acronym":59,"eligibilityCriteria":60,"healthyVolunteers":56,"sex":61,"minAge":62,"maxAge":63,"enrollmentInfo":64,"targetDuration":25,"studyType":67,"phases":68,"briefSummary":70,"conditions":71,"keywords":25,"overallStatus":38,"whyStopped":25,"lastUpdateSubmitDate":73,"lastUpdatePostDateStruct":74,"startDateStruct":77,"completionDateStruct":79,"leadSponsor":81,"locationsCount":82},{"fullName":5,"class":6},"GCS Ramsay Santé pour l'Enseignement et la Recherche","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Total prostatectomy","ACTIVE_COMPARATOR","Patient will undergo total prostatectomy as a treatment for their cancer",[13],"Procedure: Total prostatectomy",{"label":15,"type":16,"description":17,"interventionNames":18},"Focal HIFU","EXPERIMENTAL","Patient will undergo focal HIFU as a treatment for their cancer",[19],"Procedure: Focal HIFU",[21,26],{"type":22,"name":9,"description":23,"armGroupLabels":24,"otherNames":25},"PROCEDURE","Total prostatectomy is a surgical procedure performed to treat prostate cancer.",[9],null,{"type":22,"name":15,"description":27,"armGroupLabels":28,"otherNames":25},"Focal HIFU treatment is an innovative technique that consists of destroying prostate tumour cells using high-intensity ultrasound focused exclusively on the affected area of the gland.",[15],[30],{"name":31,"role":32,"phone":33,"phoneExt":25,"email":34},"Guillaume PLOUSSARD, MD","CONTACT","+33 06 84 11 85 09","dr.gploussard@gmail.com",[36],{"facility":37,"status":38,"city":39,"state":25,"zip":40,"country":41,"countryCode":42,"cosmosGeoPoint":43,"geoPoint":48,"contacts":49},"Clinique La Croix du Sud","RECRUITING","Quint-Fonsegrives","31130","France","FR",{"type":44,"coordinates":45},"Point",[46,47],1.5272,43.5852,{"lat":47,"lon":46},[50],{"name":31,"role":32,"phone":51,"phoneExt":25,"email":34},"+33 6 84 11 85 09",{"type":53,"investigatorFullName":25,"investigatorTitle":25,"investigatorAffiliation":25,"oldNameTitle":25,"oldOrganization":25},"SPONSOR","100588728","comparison-of-prostate-cancer-related-quality-of-life-in-sexually-active-men-with-favourable-intermediate-risk-localised-prostate-cancer-treated-with-total-prostatectomy-or-focal-hifu-100588728",false,"NCT06945172","Comparison of Prostate Cancer-related Quality of Life in Sexually Active Men With Favourable Intermediate-risk Localised Prostate Cancer Treated With Total Prostatectomy or Focal HIFU","QUALIFY","Inclusion Criteria:\n\n* Patient, male, aged between ≥ 40 and ≤ 75 years\n* Patient with a life expectancy \\> 10 years at the time of inclusion.\n* Patient with a therapeutic strategy (prostatectomy or focal HIFU) defined during a PCR.\n* Patient with a diagnosis of localised prostate cancer at favourable intermediate risk\n* Patient able to tolerate general anaesthesia or type IV sedation\n* Patient with normal urinary continence status\n* Patient with satisfactory erectile function allowing penetration:\n* Patient with targeted biopsies and systematic biopsies\n* Patient affiliated to or benefiting from a social security scheme\n* French-speaking patients who do not object to the use of their data.\n\nExclusion Criteria:\n\n* Patients with a contraindication to MRI\n* Stage T3a or b on MRI\n* Patient on long-term anticoagulants and unable to stop them.\n* Patient already included in another study\n* Protected patient: adult under guardianship, curatorship or other legal protection, deprived of liberty by judicial or administrative decision","MALE","40 Years","75 Years",{"count":65,"type":66},102,"ESTIMATED","INTERVENTIONAL",[69],"NA","The goal of this trial is to assess the impact of focal HIFU therapy on quality of life in patients with favourable intermediate-risk localised prostate cancer. The main question it aims to answer is:\n\nWhat is the prostate cancer-related quality of life in patients with favourable intermediate-risk localised cancer treated by total prostatectomy or focal HIFU ?\n\nResearchers will compare patients with favourable intermediate-risk localised cancer treated by total prostatectomy to patients with favourable intermediate-risk localised cancer treated by focal HIFU to see their quality of life.\n\nParticipants will answer EPIC-CP questionnaire 6 months, 12 months and 24 months after treatment",[72],"Prostate Cancer","2026-08-19",{"date":75,"type":76},"2026-08-20","ACTUAL",{"date":78,"type":76},"2025-09-01",{"date":80,"type":66},"2028-12-31",{"name":5,"class":6},1]